Anti-LATS1/WARTS (phospho T1079) + LATS2 (phospho T1041) antibody [EPR27261-8]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal LATS1/WARTS phospho T1079 antibody. Suitable for Dot, WB, ICC/IF and reacts with Synthetic peptide, Human samples. Cited in 4 publications.
View Alternative Names
WARTS, LATS1, Serine/threonine-protein kinase LATS1, Large tumor suppressor homolog 1, WARTS protein kinase, h-warts
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-LATS1/WARTS (phospho T1079) + LATS2 (phospho T1041) antibody [EPR27261-8] (AB305029)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HeLa (human cervical adenocarcinoma epithelial cell) cells labelling LATS1(phospho T1079)+LATS2 (phospho T1041) with ab305029 at 1/100 (5.0 µg/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preabsorbed antibody at 1/1000 2 µg/ml dilution (Green). Confocal image showing mainly centrosome staining in HeLa cells treated with Calyculin A (100 ng/ml) for 10 min. Image was taken with a confocal microscope(Leica-Microsystems, TCS SP8). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5µg/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preabsorbed at 1/1000 2 µg/ml dilution.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-LATS1/WARTS (phospho T1079) + LATS2 (phospho T1041) antibody [EPR27261-8] (AB305029)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HeLa (human cervical adenocarcinoma epithelial cell) cells labelling LATS1(phospho T1079)+LATS2 (phospho T1041) with ab305029 at 1/100 (5.0 µg/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preabsorbed antibody at 1/1000 2 µg/ml dilution (Green). Confocal image showing centriole (arrow) staining in HeLa cells in M phase. Image was taken with a confocal microscope(Leica-Microsystems, TCS SP8). ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5µg/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preabsorbed at 1/1000 2 µg/ml dilution.
- WB
Supplier Data
Western blot - Anti-LATS1/WARTS (phospho T1079) + LATS2 (phospho T1041) antibody [EPR27261-8] (AB305029)
Blocking and diluting buffer and concentration : 5% NFDM/TBST The antibody detects human LATS1 (phospho T1079) & LATS2 (phospho T1041). In Western blot, anti-His antibody (ab213204) staining at 1/5000 dilution. Exposure time : Lanes 1-2 : 41 seconds, lanes 3-4 and 7-8 : 180 seconds, lanes 5-6 : 10 seconds.
All lanes:
Western blot - Anti-LATS1/WARTS (phospho T1079) + LATS2 (phospho T1041) antibody [EPR27261-8] (ab305029) at 1/1000 dilution
Lanes 1 - 2:
HEK293T cells transfected with a human LATS1(S909A mutation) expression vector containing a his tag
Lanes 3 - 4:
HEK293T cells transfected with a human LATS1(T1079A mutation) expression vector containing a his tag
Lanes 5 - 6:
HEK293T cells transfected with a human LATS2(S872A mutation) expression vector containing a his tag
Lanes 7 - 8:
HEK293T cells transfected with a human LATS2(T1041A mutation) expression vector containing a his tag
Secondary
All lanes:
Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 150 kDa
false
- WB
Supplier Data
Western blot - Anti-LATS1/WARTS (phospho T1079) + LATS2 (phospho T1041) antibody [EPR27261-8] (AB305029)
Blocking and diluting buffer and concentration : 5% NFDM/TBST Lysates were freshly made and used immediately to minimize protein degradation. In Western blot, anti-LATS1 antibody (ab243656) staining at 1/1000 dilution. Anti-LATS2 antibody (ab243657) staining at 1/1000 dilution. Anti-GAPDH antibody (ab181602) loading control staining at 1/200000 dilution. Exposure time : 15 seconds
All lanes:
Western blot - Anti-LATS1/WARTS (phospho T1079) + LATS2 (phospho T1041) antibody [EPR27261-8] (ab305029) at 1/1000 dilution
Lane 1:
Untreated HeLa(human cervix adenocarcinoma epithelial cell) whole cell lysate 20 μg (untreated membrane) at 20 µg
Lane 2:
HeLa treated with 100 ng/mL Calyculin A for 10 minutes (untreated membrane)
Lane 3:
Untreated HeLa whole cell lysate 20 μg (phosphatase treated membrane) at 20 µg
Lane 4:
HeLa treated with 100 ng/mL Calyculin A for 10 minutes (phosphatase treated membrane)
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 150 kDa
false
Exposure time: 15s
- Dot
Supplier Data
Dot Blot - Anti-LATS1/WARTS (phospho T1079) + LATS2 (phospho T1041) antibody [EPR27261-8] (AB305029)
Dot blot analysis of LATS1(phospho T1079)+LATS2 (phospho T1041 using ab305029 at 1 : 1000 (0.5 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
Lane 1 : LATS1 (phospho T1079)/ LATS2 (phospho T1041) peptide a
Lane 2 : LATS1 (phospho T1079)/ LATS2 (phospho T1041) peptide b
Lane 3 : LATS1/ LATS2 non-phospho peptide a
Peptide a, b and c share 100% sequence similarity with human LATS1 and LATS2.
Exposure time : 180 seconds
Blocking and diluting buffer and concentration : 5% NFDM/TBST
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LATS1 and LATS2 are part of the core Hippo signaling complex playing roles in controlling cell growth and organ size. They achieve this by inhibiting the transcription co-activator YAP/TAZ preventing excessive cell division and promoting programmed cell death when needed. This regulation ensures proper development and suppresses tumor formation. LATS proteins act as tumor suppressors preventing the overgrowth of cells that could lead to cancerous transformations.
Pathways
LATS1 and LATS2 integrate into the Hippo signaling and apoptotic pathways. In the Hippo pathway these kinases partner with MOB1 to phosphorylate YAP/TAZ preventing their translocation into the nucleus where they might trigger oncogenic gene expression. They also interact with other proteins like MST1/2 kinases within the Hippo cascade ensuring tight regulation of cell proliferation and death.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Journal for immunotherapy of cancer 13: PubMed40789740
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 16:278 PubMed40216763
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer discovery 14:2471-2488 PubMed39058094
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:107617 PubMed37664594
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com